跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 103 条关于
“EVEREST”
全部
103
临床试验
40
药物
6
机构
11
资讯
46
去年
Taiwan Accepts Everest Medicines' VELSIPITY Application for Ulcerative Colitis Treatment
去年
Everest Medicines Advances AI-Powered mRNA Platform with Cancer Vaccine Breakthroughs
去年
FDA Clears Everest Medicines' IND Application for Novel mRNA Cancer Vaccine EVM14
11个月前
Wu Yifang Appointed Chairman of Everest Medicines as Company Advances mRNA Cancer Vaccine Platform
去年
Everest Medicines Advances mRNA Tumor Vaccine Pipeline Amidst Financial Growth
去年
Everest Medicines Raises HK$1.57 Billion to Accelerate AI+mRNA Platform and Pipeline Development
9个月前
Everest Medicines Secures Exclusive Greater China Rights to Novel PCSK9 Inhibitor Lerodalcibep
2个月前
Everest Medicines and Hainan Herui Forge Commercialization Partnership for Budesonide Enteric Capsules in China
10个月前
NovaBridge Subsidiary Visara Assigns VIS-101 License to Everest Medicines for Asian Markets
去年
Everest Medicines Invests $30.9M in I-Mab Following Promising 83% Response Rate for Gastric Cancer Bispecific Antibody
第 1 页,共 5 页
上一页
下一页